Eric B. Gordon Founder, CEO and Chairman

Mr. Gordon has a successful track record of identifying and bringing emerging medical and healthcare technologies into the clinic, industry and major market dominance. Over 30+ years, he has initiated, driven and managed through full development and/or full global commercialization seven startup companies in pediatric, adult and traveler's vaccines (Connaught Labs -now Sanofi-Pasteur, and Virogenetics); in combinatorial chemistry for drug discovery (ArQule); in clinical genomics (Ardais); in drug-delivery for endometriosis (Combinent); in HDL/CHD therapeutics (Cardium); and in behavioral health/ADHD diagnostics (BioBehavioral Diagnostics).

He began his career with Arthur Andersen & Co., and served as VP and CFO at Sterling Drug. Eric holds business degrees from Syracuse University, the University of Pennsylvania, The Wharton School.

Best Experience: "In April 2014 during our Phase II Study, a father called me at home around 9:30 in the evening, Just got home from picking up my daughter at her ballet lesson. S_____ for the first time could hold a pose for 10 seconds!!!! [in tears] Been there myself so many times."

Brad Goverman Vice President and Chief Operating Officer

Mr. Goverman has over 30 years of experience in the technology consulting industry. Most recently, he led Deloitte Consulting’s Oracle Retail practice where he was responsible for growing a new practice area focused on helping retail clients enable multi-channel capabilities and implementing the systems infrastructure to support integrated retailing platforms. Prior to leading the retail practice area, he was Deloitte’s Oracle Service Line Leader for the Northeast region, responsible for growing and managing a consulting practice of 150 professionals dedicated to implementing Oracle-based solutions for clients across multiple industries. As a senior leader at Deloitte, Brad was responsible for developing go-to-market strategies, recruiting and developing talent, and delivering high-impact solutions to his clients.

Prior to joining Deloitte Consulting, Mr. Goverman worked at Accenture and then Arthur Andersen’s Business Consulting practice for 19 years, ending with his role as the Northeast Practice Leader for the Oracle practice. Mr. Goverman has been the engagement partner or QA partner on numerous ERP and custom development projects ranging from start-up engagements to more complex global rollouts.

Brad received his B.A. in Journalism and English from the University of Massachusetts-Amherst and his M.B.A. from Babson College.

Best Experience: "After all the hard work to develop a proprietary AV™ Headset, and then see children in a local School Study use it to learn and retain new cognitive skills. And the kids thought it was so cool!"

Jeremy G. Soybel Founder, Vice President and Chief Information Officer

Mr. Soybel has 30+ years of technical, management and leadership experience in Information Communications Technology (ICT). He brings extensive knowledge and expertise on product, project and technical management in diverse development, delivery and maintenance processes, environments and technologies. As a consultant for a major Boston based ICT consulting practice, he has managed design, implementation, testing and deployment of hardware and software products/projects for research, clinical trials, medical device hardware and software deployment for employers and internal/external clients, including Ardais and BioBehavioral Diagnostics. He has architected client/server, web and alternative data entry/access systems. He has wide-ranging experience in multiple software development models, and has designed and implemented systems compliant with multiple international standards.

Jeremy holds a Bachelors degree in Chemistry from the University of Chicago, an Information Systems certification from Bentley University, and has authored four software development/engineering texts.

Best Experience: "In home studies, seeing the total transformation of a child's cognitive skill set as he realized what focused and sustained attention meant and that he could actually control it!"

Priyadharshini GaneshSoftware Engineer

Priya has 8 years of experience as a software engineer developing web, client/server and desktop solutions in a variety of industries. She is responsible for implementation of APIs/Services and infrastructure for game development. She holds a Bachelor Degree in Information Technology from Amrita University, India and prior to Atentiv she was a software programmer in TATA Consultancy Services Ltd, India. It is her pleasure to work with Atentiv to help create solutions for optimizing attention and impulse control.

Best Experience: "Seeing how our technology could be applied in a game curriculum and then seeing the data that evidence's a genuine solution for attention and impulse control."

Neal Grigsby Creative Director

Neal has spent over 15 years developing products that have defied easy categorization but that have shared a common purpose: to education, entertain, and empower. He studied games and learning in MIT’s Comparative Media Studies program, concluding with the design of a genre-bending mobile game for the MIT Game Lab that earned a nomination for Best Mobile Game at the Independent Games Festival. He has since applied his understanding of user experience design, digital media, Agile software development, and storytelling to diverse products such as a self-publishing platform for kids and a video-sharing site for teachers. At Atentiv, he manages the development of our video games, working with the game development team and experts in cognitive training to create narrative-rich experiences that improve a player's cognitive skills. Neal lives and works in Oakland, California with his wife and two children.

Best Experience: "Seeing Skylar’s Run: an epic story that I helped create, that challenges a player to learn and improve just as much as the main character, leveling-up their own brains with the skills that will enable success in their real lives. They get to play the game with their own mind. A truly inspiring project!"

Ashley McDermott Ph.D. Senior Manager, Evidence Development and Cognitive Science

Dr. McDermott, PhD oversees the Evidence Development Team and works closely with our game designers to develop appropriate game mechanics to train cognitive skills. She has over 10 years of experience as a cognitive science researcher. Her research has primarily focused on how to leverage the benefits of playing video games to improve cognition and learning throughout the lifespan, from children to the elderly. She has designed and coordinated several training studies using specific games in college students, children, and older adults. Ashley brings a passion for harnessing the power of game-based learning through good design grounded in science.

Ashley received her B.S. in Psychology from Carnegie Mellon University and her M.A. and Ph.D. in Brain and Cognitive Sciences from the University of Rochester.

Best Experience: "Over the course of home studies training, watching a child go from throwing a tantrum every time he did something wrong to being able to calm himself and continue with the game."

Arman Oganesian Sr. Software Architect

Mr. Oganesian has over 20 years of combined experience in software architecture, development and technical team leadership. Prior to joining Atentiv he lead the online marketplace portal and machine translation development teams at Lionbridge, Waltham. Arman’s expertise ranges from online web portals and enterprise applications to mobile back-end management systems and multi-platform mobile solutions. At Atentiv Arman is responsible for Atentiv SDK and RDC architecture and helping with the development of back-end systems and mobile games.

Arman holds bachelor degree in Geophysics from Yerevan University, Armenia and a certificate in systems design and development from CLC.

Best Experience: "After integrating the algorithm, game and hardware elements and realizing the positive impact tthat ATENTIVmynd™ Games will have on children, adults and their families."

Maya Rose Study Coordinator

Maya Rose is a Study Coordinator on the Evidence Development Team. She has designed, coordinated and analyzed school, clinical and home studies and has trained over 100 ADHD children with ATENTIVmynd™ Games. With her knowledge and experience with ADHD children and their parents, Maya has contributed significantly to product development. She holds a BA in Psychology from Dickinson College where she conducted honors research on the effects of early diagnosis and intervention on achievement, self-regulation and self-determination among children with ADHD and learning disabilities. Previously, she was a research assistant for the New York State Psychiatric Institute/Columbia University and conducted epidemiological research on the mental health outcomes of children with parents who have had criminal justice system involvement.

Maya’s personal and professional experience has fueled a passion for designing game-based training curriculums for children, which can be made readily accessible to educators. She is pursuing a PhD in Educational Psychology in the Fall of 2016.

Best Experience: "Watching dozens of ADHD children in school and home studies successfully play, enjoy and train their attention skills with the ATENTIVmynd™ Games I helped create."

Board of Directors

Eric B. Gordon Founder, CEO and Chairman

Marcia A. Kean Director

Marcia A. Kean is Chairman, Strategic Initiatives, Feinstein Kean Healthcare. Marcia Kean has built Feinstein Kean Healthcare's unique national role as a strategy and communications consultancy in the life sciences and healthcare since the firm's inception 25+ years ago. She served as the Chief Executive Officer of the firm from 2002 to 2011, and became Chairman, Strategic Initiatives in 2011. Throughout her career, Marcia has stood alongside innovators whose disruptive technologies and ideas have transformed the landscape of biomedicine. She has counseled dozens of senior management teams in corporate positioning and product communications, crisis communications, investor relations, and constituency-building. Her clients have included Big Pharma companies; start-ups in biopharma, device, informatics, personal health and clinical decision support; policy organizations; academic/medical centers; patient advocacy groups; and federal government agencies. Marcia was a member of the Board of Trustees of the MFS Compass Funds from 2005 to 2011, and served as chair of that Board's Governance and Compliance Committee.

Marcia holds an M.B.A. in finance from New York University and a B.A. from the University of California at Berkeley.

Ranga Krishnan, M.D. Director

Dr. Krishnan, MB ChB, is the dean of Rush Medical College and Senior Vice President of Rush University Medical Center. He served for seven years as the dean of the Duke-NUS Graduate Medical School in Singapore. He also is an international expert in treating depression and other brain disorders of the elderly. Dr. Krishnan has written three books, more than 50 textbook chapters and more than 400 journal articles on the subjects of elderly depression, dementia, Alzheimer’s disease, panic disorder, bipolar disorder in late life and obsessive-compulsive disorder, among others.

He has received international recognition for his work, including being listed in Marquis’ Who’s Who in Science and Engineering. He received the Distinguished Investigator Award from the National Alliance for Research on Schizophrenia and Depression, and served as chairman of the clinical neurosciences and biological psychopathology review committee of the National Institute of Mental Health.

A native of Madras, India, Dr. Krishnan received his medical degree from Madras Medical College. He came to Duke in 1981 as a psychiatry resident after completing internships in India and the West Indies. He was chief resident in psychiatry from 1982-83 and a fellow in neurobiology at Duke until 1984. Dr. Krishnan was appointed as a faculty member in 1985 and ascended to medical director of the affective disorders unit in 1989. He was named chair of the Department of Psychiatry in 1998.

Ernest H. PomerantzDirector

Ernest H. Pomerantz is Chairman of StoneWater Capital, LLC and has more than 30 years of experience in private equity and venture investing. Prior to joining StoneWater Capital, he was Managing Director with Mesa Partners, LLC and before that, a partner at Warburg, Pincus & Company for 22 years. Previously, he was a Vice President at Lehman Bros-Kuhn, Loeb & Co. Mr. Pomerantz is currently a Director of Alamo Orchards, Inc., Christcot Medical Company, Gracious Eloise, MedicaMetrix Inc., Multimedia Plus Inc., PingMD Inc. and Tribeca Flashpoint Media Arts Academy. He is also a Director of Phoenix House Foundation.

Mr. Pomerantz served as a Lieutenant in the United States Navy from 1964 to 1969. He received a B.S. degree from Rensselaer Polytechnic Institute with a Navy ROTC Scholarship, an M.A. from USC/London School of Economics, and an M.B.A. from New York University.

Robert L. Taber, Ph.DDirector

Robert L. Taber, Ph.D. served as Vice Chancellor for Corporate and Venture Development at Duke University Medical Center and Health System for 20 years until his retirement in January 2012. Dr. Taber continues at Duke in a part time role as Senior Advisor to the Chancellor for Global Strategies.

He received his A.B. degree from Harpur College, a Ph.D. from the University of Pittsburgh School of Medicine, and did an American Cancer Society Postdoctoral fellowship at MIT with Professor David Baltimore. He had a series of academic appointments at University of Massachusetts School of Medicine, Roswell Park Memorial Institute and Stanford University. He left academics to participate in the founding of Integrated Genetics and while at Duke was a founder of Hermes Biosciences, both of which had successful public offerings. He was also President for five years of EG&G MRI, a division of the parent EG&G (now known as Perkin Elmer).

While at Duke, he initiated and led the negotiations that resulted in the Duke-National University School of Medicine. He remains closely involved with this $800 million initiative. In addition to his part-time role at Duke, he is also involved in multiple initiatives in the Middle East and Asia.

Scientific Advisory Board

Ranga Krishnan, M.D. Founding Consultant

Edward Hallowell, M.D., Ed.D. Consultant – Clinical Practices

Dr. Hallowell is a child and adult psychiatrist and the founder of The Hallowell Center for Cognitive and Emotional Health in Sudbury, MA and New York City. Dr. Hallowell is considered to be one of the foremost experts on the topic of ADHD and is a highly recognized speaker around the world. He has presented to thousands on topics such as ADD strategies on handling your fast paced life, the Childhood Roots of Adult Happiness and other pertinent family and health issues. He has been prominently featured in the media including 20/20, Oprah, CNN, PBS and NPR as well as 60 Minutes, The Today Show, Dateline, Good Morning America, US News and World Report, Newsweek, the Harvard Business Review and the New York Times. He is the co-author, with Dr. John Ratey, of Driven to Distraction and Answers to Distraction, which have sold more than a million copies. In 2005, Drs. Hallowell and Ratey released their much-awaited third book on ADHD, Delivered from Distraction. He was a member of the faculty of the Harvard Medical School from 1983 to 2004 until he retired to devote his full professional attention to his clinical practice, lectures, and the writing of books.

Dr. Hallowell is a graduate of Harvard College and Tulane School of Medicine.

Scott Kollins, Ph.D. Consultant, Clinical Validation Strategy

Dr. Kollins is a tenured Professor and Vice-Chair for Research Strategy and Development in the Department of Psychiatry and Behavioral Sciences; and a Professor in the Department of Psychology and Neuroscience at Duke University. He has been a member of the Duke faculty since 2000. He is also the Director of the Duke ADHD Program. He received his undergraduate degree in psychology from Duke University in 1992 and earned his Master’s and Doctorate degrees in Clinical Psychology from Auburn University in 1995 and 1997, respectively. Scott completed his clinical internship at the University of Mississippi Medical Center, where he served as Chief Intern.

Scott has published more than 120 scientific papers in peer-reviewed journals. Over the past 10 year’s, Scott’s research has been supported by 5 different federal agencies, including NIDA, NIMH, NIEHS, NINDS, and EPA. He currently holds a mid-career K24 award from NIDA. Scott has also served as PI on more than 30 industry-funded clinical trials and is a consultant to a number of pharmaceutical companies in the area of ADHD clinical psychopharmacology. Scott is an elected member of both the College on Problems of Drug Dependence and the American College of Neuropsychopharmacology and is a Fellow of the American Psychological Association Division 28 (Psychopharmacology and Substance Abuse). He was formerly a standing member of the Child Psychopathology and Developmental Disabilities study section and has served as an ad-hoc reviewer for 10 additional NIH study sections and 7 international granting agencies. He is an Associate Editor for the Journal of Attention Disorders and has reviewed for more than 50 different peer-reviewed journals.

Scott is a licensed clinical psychologist and maintains a practice through the ADHD Program’s outpatient clinic. Scott’s research interests are in the areas of psychopharmacology and the intersection of ADHD and substance abuse, particularly cigarette smoking.

Andrew Krystal, M.D. Consultant, Quantitative Electroencephalography

Dr. Krystal is Professor, Psychiatry and Behavioral Science, UCSF,
Executive Vice-Chair, Langley Porter Psychiatric Institute, UCSF
Director, Sleep Research Program, UCSF; Mood Disorders Program, UCSF
Ray and Dagmar Dolby Distinguished Professor of Psychiatry, UCSF.

His research is focused on mood disorders following 30 years of treating patients with mood disorders. His work includes: identifying EEG indices that can be used to improve the clinical dosing of electroconvulsive therapy (ECT) for patients with treatment-resistant depression; carrying out pivotal trials of repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depression; carrying out a pivotal trial of the antidepressant effects of transcranial direct current therapy (tDCS); completing trials evaluating whether cognitive behavioral therapy and pharmacotherapy for insomnia augment the antidepressant response to SSRI and SNRI medications; completing studies developing physiologic biomarkers that are predictors and correlates of the response to the rapidly acting antidepressant ketamine, and cognitive behavioral therapy in depressed patients; serving as overall PI of the NIMH Contract “New Experimental Medicine Studies: Fast-Fail Trials in Mood and Anxiety Spectrum Disorders (FAST-MAS.)”Also leads a a multi-site team in carrying out trials of promising new therapies for mood and anxiety spectrum disorders using novel neuroscience-based early phase methodologies.

Dr. Krystal completed his medical training at Duke University School of Medicine. Dr. Krystal also completed a residency in Psychiatry, his Clinical Research Methodology and a fellowship in Clinical Neurophysiology at Duke University Medical Center.

John Ratey, M.D. Consultant, Clinical Practices

John J. Ratey, MD, is an Associate Clinical Professor of Psychiatry at Harvard Medical School, Research Synthesizer, Speaker, and best selling Author. He has published over 60 peer-reviewed articles on the topics of Aggression, Autism, ADHD, and other issues in Neuropsychiatry, and written 8 books published in 14 languages. Dr. Ratey is the co-author of the ground breaking ADD-ADHD series of books, “Driven to Distraction,” “Answers to Distraction,” and "Delivered from Distraction,” with Edward Hallowell, MD. First published in 1994, “Driven to Distraction” is still considered the seminal book on ADD-ADHD, and to this day remains a best seller in the field.

In addition, Dr. Ratey is the author of “A Users Guide to the Brain” (2000) and co-author of “Shadow Syndromes” (1997) with Catherine Johnson, PhD., both published by Pantheon/Random House. He has edited several academic publications, including “The Neuropsychiatry of Personality Disorders”(1994), published byBlackwell Scientific. Consistently named one of the Best Doctors in America by his peers, Dr. Ratey and his work are frequently profiled in the media, where he’s been featured on ABC, CBS, NBC, PBS and NPR, and well as in The New York Times, Newsweek, The Washington Post, US News and World Report, Forbes, Men’s Health, Fitness Magazine, and other national publications.

Dr. Ratey maintains a private practice in Cambridge, Massachusetts, and recently completed and published by Little Brown a new book examining our genetic roots and the influence on our psychology in a modern world, titled, “Go Wild.”

Tony Wagner, Ed.D. Consultant, Education

Dr. Wagner has served as co-director of the Change Leadership Group (CLG) at the Harvard Graduate School of Education since its inception in 2000. An initiative of the Bill & Melinda Gates Foundation, CLG is a knowledge-development and capacity-building organization focused on helping teens become effective change leaders in school and district improvement. He was also on the faculty of the Executive Leadership Program for Educators, a joint initiative of Harvard’s Graduate School of Education, Business School, and Kennedy School of Government. Dr. Wagner consults widely to public and independent schools, districts, and foundations around the country and internationally, and served as Senior Advisor to the Bill & Melinda Gates Foundation for eight years. Dr. Wagner’s publications include numerous articles and four books: The Global Achievement Gap: Why Even Our Best Schools Don’t Teach the New Survival Skills Our Children Need, And What We Can do About It; Change Leadership: A Practical Guide to Transforming Our Schools; Making the Grade: Reinventing America’s Schools; and How Schools Change: Lessons from Three Communities Revisited. Dr. Wagner’s latest book is Creating Innovators: The Making of Young People Who Will Change The World.

Having worked for more than 35 years in the field of school improvement, Dr. Wagner is a frequent keynote speaker and widely published author on education and society. Prior to assuming his current position at Harvard, he was a high school teacher for 12 years, a school principal, a university professor in teacher education, co-founder and first executive director of Educators for Social Responsibility, project director for the Public Agenda Foundation in New York, and President and CEO of the Institute for Responsive Education.

He earned a Ph.D. in education at Harvard University.


Not sure where to begin

Fill out our simple form or set up a call with one of our helpful representatives


We are always happy to help.

Please fill out a form request for a live chat or call.